Novel pyrazol derivatives
US-2015376192-A1 · Dec 31, 2015 · US
Substituted xanthine derivatives
US8952016B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8952016-B2 |
| Application number | US-87404910-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 1, 2010 |
| Priority date | Feb 27, 2009 |
| Publication date | Feb 10, 2015 |
| Grant date | Feb 10, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention relates to novel compounds that are substituted xanthine derivatives and pharmaceutically acceptable salts thereof. For example, this invention relates to novel substituted xanthine derivatives that are derivatives of pentoxifylline. The compound of the invention are represented by one of the following structural formulas: The variables for these structural formulas are described herein. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions for which pentoxifylline and related compounds are beneficial.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of Formula C: or a pharmaceutically acceptable salt thereof, wherein R 1 is selected from —CH 3 and —CD 3 ; R 5 is hydrogen or deuterium; and Y is fluorine, wherein the compound has at least 50.1% deuterium incorporation at each position designated as deuterium. 2. The compound of claim 1 , wherein R 1 is —CH 3…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8952016B2 cover?
- This invention relates to novel compounds that are substituted xanthine derivatives and pharmaceutically acceptable salts thereof. For example, this invention relates to novel substituted xanthine derivatives that are derivatives of pentoxifylline. The compound of the invention are represented by one of the following structural formulas: The variables for these struct…
- Who is the assignee on this patent?
- Tung Roger D, Liu Julie F, Harbeson Scott L, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification C07D473/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).